Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 229

1.

Hypoplastic myelodysplastic syndromes can be distinguished from acquired aplastic anemia by CD34 and PCNA immunostaining of bone marrow biopsy specimens.

Orazi A, Albitar M, Heerema NA, Haskins S, Neiman RS.

Am J Clin Pathol. 1997 Mar;107(3):268-74.

PMID:
9052376
[PubMed - indexed for MEDLINE]
2.

Hypoplastic myelodysplastic syndromes can be distinguished from acquired aplastic anaemia by bone marrow stem cell expression of the tumour necrosis factor receptor.

Kasahara S, Hara T, Itoh H, Ando K, Tsurumi H, Sawada M, Yamada T, Ohnishi H, Moriwaki H.

Br J Haematol. 2002 Jul;118(1):181-8.

PMID:
12100146
[PubMed - indexed for MEDLINE]
3.

Expression of the proliferating cell nuclear antigen in bone marrow cells from patients with myelodysplastic syndromes and aplastic anemia.

Kitagawa M, Kamiyama R, Kasuga T.

Hum Pathol. 1993 Apr;24(4):359-63.

PMID:
8098317
[PubMed - indexed for MEDLINE]
5.

Phenotypic and functional analysis of bone marrow progenitor cell compartment in bone marrow failure.

Maciejewski JP, Anderson S, Katevas P, Young NS.

Br J Haematol. 1994 Jun;87(2):227-34.

PMID:
7524621
[PubMed - indexed for MEDLINE]
6.

Comparative multi-color flow cytometric analysis of cell surface antigens in bone marrow hematopoietic progenitors between refractory anemia and aplastic anemia.

Otawa M, Kawanishi Y, Iwase O, Shoji N, Miyazawa K, Ohyashiki K.

Leuk Res. 2000 Apr;24(4):359-66.

PMID:
10713334
[PubMed - indexed for MEDLINE]
7.

CD34/QBEND10 immunostaining in bone marrow biopsies: an additional parameter for the diagnosis and classification of myelodysplastic syndromes.

Baur AS, Meugé-Moraw C, Schmidt PM, Parlier V, Jotterand M, Delacrétaz F.

Eur J Haematol. 2000 Feb;64(2):71-9.

PMID:
10997326
[PubMed - indexed for MEDLINE]
8.

QBEND10 for the diagnosis of myelodysplastic syndromes in routinely processed bone marrow biopsy specimens.

Horny HP, Wehrmann M, Schlicker HU, Eichstaedt A, Clemens MR, Kaiserling E.

J Clin Pathol. 1995 Apr;48(4):291-4.

PMID:
7542289
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Histological and cytogenetic characterization of bone marrow in relation to prognosis and diagnosis of myelodysplastic syndromes.

Sakuma T, Hayashi Y, Kanomata N, Murayama T, Matsui T, Kajimoto K, Hanioka K, Chihara K, Maeda S.

Pathol Int. 2006 Apr;56(4):191-9.

PMID:
16634964
[PubMed - indexed for MEDLINE]
10.

Comparative analysis of the in vitro proliferation and expansion of hematopoietic progenitors from patients with aplastic anemia and myelodysplasia.

Martínez-Jaramillo G, Flores-Figueroa E, Sánchez-Valle E, Gutiérrez-Espíndola G, Gómez-Morales E, Montesinos JJ, Flores-Guzmán P, Chávez-González A, Alvarado-Moreno JA, Mayani H.

Leuk Res. 2002 Oct;26(10):955-63.

PMID:
12163058
[PubMed - indexed for MEDLINE]
11.

Immunophenotype of myeloid granulocytes: a pilot study for distinguishing myelodysplastic syndrome and aplastic anemia by flow cytometry.

Huang M, Li J, Zhao G, Sui X, Zhao X, Xu H.

Int J Lab Hematol. 2010 Jun;32(3):275-81. doi: 10.1111/j.1751-553X.2009.01192.x. Epub 2009 Nov 30.

PMID:
19968721
[PubMed - indexed for MEDLINE]
12.

[Expression of G-CSF and GM-CSF receptors on CD34 positive cells in aplastic anemia and myelodysplastic syndrome patients and its significance].

Xu HZ, Li A, Yu Y, Li JF, Liu X, Wang XH, Wang X, Xu GL.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Dec;16(6):1308-11. Chinese.

PMID:
19099633
[PubMed - indexed for MEDLINE]
13.
14.

CD34, RAB20, PU.1 and GFI1 mRNA expression in myelodysplastic syndrome.

Huh HJ, Chae SL, Lee M, Hong KS, Mun YC, Seong CM, Chung WS, Huh JW.

Int J Lab Hematol. 2009 Jun;31(3):344-51. doi: 10.1111/j.1751-553X.2008.01056.x. Epub 2008 Mar 25.

PMID:
18371060
[PubMed - indexed for MEDLINE]
15.
16.

Myelodysplastic syndromes: immunohistochemical and morphometric evaluation of proliferative activity in erythropoiesis and endoreduplicative capacity of megakaryocytes.

Thiele J, Hoffmann I, Bertsch HP, Fischer R.

Virchows Arch A Pathol Anat Histopathol. 1993;423(1):33-8.

PMID:
8105604
[PubMed - indexed for MEDLINE]
17.

CD34 immunohistochemistry of bone marrow biopsies: prognostic significance in primary myelodysplastic syndromes.

Soligo DA, Oriani A, Annaloro C, Cortelezzi A, Calori R, Pozzoli E, Nosella D, Orazi A, Deliliers GL.

Am J Hematol. 1994 May;46(1):9-17.

PMID:
7514357
[PubMed - indexed for MEDLINE]
18.

The assessment of proliferating cell nuclear antigen immunostaining in myelodysplastic syndromes and its prognostic significance.

Alexandrakis MG, Passam FH, Dambaki K, Passam AM, Nalbanti F, Stathopoulos ES, Kyriakou DS.

Eur J Histochem. 2005 Jan-Mar;49(1):27-32.

PMID:
15823791
[PubMed - indexed for MEDLINE]
19.

Effects of antithymocyte globulin on bone marrow CD34+ cells in aplastic anaemia and myelodysplasia.

Killick SB, Marsh JC, Gordon-Smith EC, Sorlin L, Gibson FM.

Br J Haematol. 2000 Mar;108(3):582-91.

PMID:
10759717
[PubMed - indexed for MEDLINE]
20.

[A study of hypoplastic myelodysplastic syndrome].

Sato Y, Mituhashi S, Otani K, Kamoshita M, Hasegawa Y, Ninomiya H, Nagasawa T, Abe T.

Rinsho Ketsueki. 1993 Nov;34(11):1431-7. Japanese.

PMID:
8254904
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk